相关实验视频

Updated: Aug 10, 2026

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice

Orthotopic Ovarian Transplantation Procedures to Investigate the Life- and Health-span Influence of Ovarian Senescence in Female Mice

Published on: February 12, 2018

德尔塔阿片类酸[d-Ala2,d-Leu5]-脑改善身体和认知功能,并增加老年雌性小鼠的寿命

Lixia Huo¹, Hongquan Zhang¹, Chengwu Tang¹

¹Huzhou Key Laboratory of Translational Medicine, The First Affiliated Hospital of Huzhou University, The First People's Hospital of Huzhou, Huzhou, 313000, Zhejiang Province, China.

Molecular neurobiology

|September 23, 2024

概括

[d-Ala2,d-Leu5]-enkephalin (DADLE) 显著延长寿命并改善老年小鼠的健康状况. 这种可以减少炎症,增强认知和运动功能,并保持端粒长度,提供一种新的抗衰老策略.

科学领域:

老年学和衰老研究研究.
神经科学是一个神经科学.
免疫学免疫学免疫学

背景情况:

全球人口老龄化需要新的抗老策略.
了解衰老的分子机制对于开发干预措施至关重要.
炎症和代谢途径在衰老中的作用需要进一步研究.

研究的目的:

在老哺乳动物中研究[d-Ala2,d-Leu5]-enkephalin (DADLE) 的抗衰老潜力.
为了确定DADLE是否可以通过抗炎和代谢作用改善健康和寿命.
阐明DADLE对衰老的影响背后的分子机制.

主要方法:

对年龄较大的雌性C57/BL6J小鼠给予DADLE.
使用行为测试评估认知和运动功能.
在大脑和心脏中分析衰老生物标志物 (P16INK4A,Lamin B1,sirtuin 1).
测量血清促炎细胞因子和端粒长度.
对大脑和心脏组织的转录组分析.

主要成果:

在老年小鼠中,DADLE治疗显著改善了运动和认知功能.
DADLE的使用延长了老老老鼠的寿命.
DADLE在大脑和心脏中增加了抗衰老标志物和减少了亲衰老标志物.
通过减少促炎细胞因子和炎症细胞透,DADLE减轻了与年龄相关的炎症.
DADLE补充剂显著延长了相对端粒长度,并调节了免疫和细胞信号通路.

结论:

外源性DADLE对老年哺乳动物具有显著的益处,改善了健康和寿命.
DADLE通过减少炎症,增强细胞健康和保持端粒长度来发挥其抗衰老作用.
DADLE代表了一种有前途的治疗候选药物,用于对抗与年龄相关的衰退和促进长寿.

关键词:

在老老的老鼠身上认知功能认知功能脑内含有脑神经元 (Enkephalin) 的寿命寿命寿命寿命寿命运动功能运动功能

更多相关视频

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration

Published on: February 27, 2018

Lipid Supplementation for Longevity and Gene Transcriptional Analysis in Caenorhabditis elegans

Lipid Supplementation for Longevity and Gene Transcriptional Analysis in Caenorhabditis elegans

Published on: December 9, 2022

相关概念视频

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...